High levels of proinflammatory cytokines, but not markers of tissue injury, in unaffected intestinal areas from patients with IBD
about
Characterization of interleukin-17-producing regulatory T cells in inflamed intestinal mucosa from patients with inflammatory bowel diseasesPulmonary-intestinal cross-talk in mucosal inflammatory diseaseMatrix metalloproteinases in inflammatory bowel disease: an updateAssessment of Disease-Related Therapeutic Protein Drug-Drug Interaction for Etrolizumab in Patients With Moderately to Severely Active Ulcerative ColitisMultivariate modeling identifies neutrophil- and Th17-related factors as differential serum biomarkers of chronic murine colitis.IL-15: a central regulator of celiac disease immunopathology.Validated gene expression biomarker analysis for biopsy-based clinical trials in ulcerative colitis.Silk fibroin nanoparticles constitute a vector for controlled release of resveratrol in an experimental model of inflammatory bowel disease in rats.Interleukin-1 associations in inflammatory bowel disease and the enteropathic seronegative spondylarthritis.Validation of gene expression biomarker analysis for biopsy-based clinical trials in Crohn's diseaseThrombospondin peptide ABT-898 inhibits inflammation and angiogenesis in a colitis modelPegylated arginine deiminase downregulates colitis in murine models.Immune markers and differential signaling networks in ulcerative colitis and Crohn's diseaseIntestinal anti-inflammatory effects of RGD-functionalized silk fibroin nanoparticles in trinitrobenzenesulfonic acid-induced experimental colitis in rats.Interleukin 27: a double-edged sword for offense and defense.Mucosal biomarkers in inflammatory bowel disease: key pathogenic players or disease predictors?Cells, cytokines and inflammatory bowel disease: a clinical perspective.Results of the 2nd scientific workshop of the ECCO (III): basic mechanisms of intestinal healing.Regulatory T cells in inflammatory bowel diseases and colorectal cancer.Blessing or curse? Proteomics in granzyme research.Adenovirus type 5 rupture of lysosomes leads to cathepsin B-dependent mitochondrial stress and production of reactive oxygen species.Assessment of disease activity in pediatric ulcerative colitis.Interleukin-27 as a Novel Therapy for Inflammatory Bowel Disease: A Critical Review of the Literature.The molecular biology of matrix metalloproteinases and tissue inhibitors of metalloproteinases in inflammatory bowel diseases.Interferon-gamma signals via an ERK1/2-ARF6 pathway to promote bacterial internalization by gut epithelia.Treatment with IL-27 attenuates experimental colitis through the suppression of the development of IL-17-producing T helper cells.Recombinant adeno-associated virus carrying thymosin β4 suppresses experimental colitis in mice.Cytokine production profile in intestinal mucosa of paediatric inflammatory bowel disease.Modified Pulsatilla decoction attenuates oxazolone-induced colitis in mice through suppression of inflammation and epithelial barrier disruption.Crohn's Disease and Ulcerative Colitis Show Unique Cytokine Profiles.Biomarkers in inflammatory bowel diseases: insight into diagnosis, prognosis and treatment.Interleukin-18 facilitates neutrophil transmigration via myosin light chain kinase-dependent disruption of occludin, without altering epithelial permeability.Interleukin-15 promotes intestinal dysbiosis with butyrate deficiency associated with increased susceptibility to colitis.Modulation of VIPergic phenotype of enteric neurons by colonic biopsy supernatants from patients with inflammatory bowel diseases: Involvement of IL-6 in Crohn's disease.Intestinally-restricted Janus Kinase inhibition: a potential approach to maximize the therapeutic index in inflammatory bowel disease therapy.Impairment of Small Intestinal Function in Ulcerative Colitis: Role of Enteric Innervation.Toll-like receptors-mediated pathways activate inflammatory responses in the esophageal mucosa of adult eosinophilic esophagitis.Gene expression of tumor necrosis factor receptor associated-factor (TRAF)-1 and TRAF-2 in inflammatory bowel disease.Multigene analysis unveils distinctive expression profiles of helper T-cell-related genes in the intestinal mucosa that discriminate between ulcerative colitis and Crohn's disease
P2860
Q24607561-426F57C5-3340-48AB-9773-570CB1810B5EQ27693862-D9B50CC6-5A52-42C3-A8BC-4B13FF25498DQ28080664-18639624-AF7E-4DDC-8227-E289E8782B59Q28597396-E5F19F3E-BC89-4B32-AA6C-4F8E9EDFC70AQ33728144-8934E26D-5F50-48FB-946A-F2700F09D922Q33788829-E25BEB4D-6CB5-42AD-B1B0-25C5D6052256Q34084800-10F29F62-2713-49EF-A9AB-0C3AE1678F7BQ34274578-43F8DD15-9693-4058-9F76-13EB9446FA25Q35309145-24F3AD4F-886C-4EC1-ADFB-2A93A37F39C1Q35498214-B9A2DBE9-45D0-446A-A42B-75F89E51082BQ35651465-464E9D49-74D7-4046-970A-A823361DB415Q35725419-1C8EF8E2-7FE7-4ACF-A284-756FE342CACBQ36125752-26A8648C-09F6-46C8-A77C-30F4B7D95502Q37413157-986181C5-B2CE-4925-A85D-26CA1FF22C2DQ37607910-8990E2DF-B758-4B29-9242-658D86CBAEA3Q37762230-C45D8C0E-B0E0-4F99-B328-CA4812D9C8AEQ37948155-F4DA4BA8-A846-40BC-B0D7-2073E73E3B06Q37992246-ADD99168-9B6C-4B9D-A2D8-EFA14AE39086Q38060115-241D21AA-3D19-4AD5-BA63-34BF81B01F7FQ38200060-CEB96312-0E3B-4768-83BE-83907A6C2025Q38631756-76AD1B18-602C-4691-AB06-B38AB03B2D82Q38825374-3F5EE5C9-E91F-413F-A2EC-14244AFF2D46Q38848936-1B0F5F27-D411-46DA-B9CF-EB006FF865ECQ38881849-ED9A2C80-821F-414C-B488-F7DE22A5C604Q39371803-3808D710-7D47-4845-86DE-A567F3417A76Q39613832-9F51C8C7-918C-4A39-9B8F-34C66DA50962Q40362677-82B5DFD6-8A85-4022-9B3F-F0DBB8F435B2Q41348755-674258FA-A756-4C9B-94F5-F324D88BE1A8Q41834962-FE445624-389B-44FB-A5A5-AEB4E23AB1EBQ42255132-0C78C424-8E60-4E09-BB53-68541CB1D0DCQ45898977-55A00B14-34CA-43F2-99FA-67C0EFA563DFQ46037099-B77EC67E-72B8-4BFE-8FAD-234F2276556EQ46487529-39A73157-E101-424A-9A5F-BB283BED40F6Q47817542-A61B6916-0808-4BA8-B1AF-73D717E4152EQ49624659-9151B2FD-6DF9-4C76-B25D-439229F80B0EQ51477530-2BEB47C6-E5E9-414E-8155-C789FD989C4DQ53821621-7416E627-7E88-48D3-9713-3B8B1D933CBBQ54271785-DE3F5FAC-A2AE-400C-BC66-2399533DDAD8Q57110341-30A8DA3D-2274-43F5-9162-78A5E4568133
P2860
High levels of proinflammatory cytokines, but not markers of tissue injury, in unaffected intestinal areas from patients with IBD
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 30 July 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
High levels of proinflammatory ...... l areas from patients with IBD
@en
High levels of proinflammatory ...... areas from patients with IBD.
@nl
type
label
High levels of proinflammatory ...... l areas from patients with IBD
@en
High levels of proinflammatory ...... areas from patients with IBD.
@nl
prefLabel
High levels of proinflammatory ...... l areas from patients with IBD
@en
High levels of proinflammatory ...... areas from patients with IBD.
@nl
P2093
P2860
P50
P356
P1476
High levels of proinflammatory ...... l areas from patients with IBD
@en
P2093
Alberto J León
Alfredo Blanco-Quirós
Asterio Barrera
Benito Velayos
Eduardo Arranz
Emma Gómez
Jose L Marcos
P2860
P304
P356
10.1155/2009/580450
P577
2009-07-30T00:00:00Z